World's Best Scientists 2026 revealed!
Eric Oksenhendler

Eric Oksenhendler

D-Index & Metrics

Immunology

D-Index
94
Citations
34858
World Ranking
925
National Ranking
31

Medicine

D-Index
94
Citations
34855
World Ranking
10433
National Ranking
326

Overview

Eric Oksenhendler is affiliated with Université Paris Cité in France and has a research focus primarily within the field of medicine, contributing substantially to subfields such as oncology, immunology, pathology and forensic medicine, genetics, and infectious diseases.

The scientist's work spans a wide range of topics including:

  • Viral-associated cancers and disorders
  • Immunodeficiency and autoimmune disorders
  • Lymphoma diagnosis and treatment
  • Blood disorders and treatments
  • Cytomegalovirus and herpesvirus research
  • Parvovirus B19 infection studies
  • Chronic lymphocytic leukemia research

Eric Oksenhendler has published extensively in several key venues recognized in the medical research community. The most frequent venues for their publications include:

  • Journal of Clinical Immunology
  • Blood Advances
  • Blood
  • British Journal of Haematology
  • American Journal of Hematology

Some of the recent papers associated with this researcher include:

  • Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee, 2020, Journal of Clinical Immunology
  • Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee, 2022, Journal of Clinical Immunology
  • Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification, 2020, Journal of Clinical Immunology
  • The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity, 2022, Journal of Clinical Immunology
  • International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease, 2020, Blood Advances

The researcher collaborates frequently with several co-authors, who appear regularly in their publications. These include:

  • David Boutboul (31 co-authored publications)
  • Lionel Galicier (25 co-authored publications)
  • Laurence Gérard (16 co-authored publications)
  • Véronique Meignin (15 co-authored publications)
  • Marion Malphettes (13 co-authored publications)

Best Publications

  • Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease

    Jean Soulier;Laurence Grollet;Eric Oksenhendler;Patrice Cacoub

  • Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee

    Unknown

  • Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

    Stuart G. Tangye;Waleed Al-Herz;Aziz Bousfiha;Talal Chatila

  • The EUROclass trial: defining subgroups in common variable immunodeficiency

    Claudia Wehr;Teemu Kivioja;Christian Schmitt;Berne Ferry

  • International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity

    Capucine Picard;H. Bobby Gaspar;Waleed Al-Herz;Aziz Bousfiha

  • Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015

    Capucine Picard;Waleed Al-Herz;Aziz Bousfiha;Jean Laurent Casanova

  • Clinical picture and treatment of 2212 patients with common variable immunodeficiency

    Benjamin Gathmann;Nizar Mahlaoui;Laurence Gérard;Eric Oksenhendler

  • Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.

    Aziz Bousfiha;Leila Jeddane;Capucine Picard;Waleed Al-Herz

  • International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

    David C. Fajgenbaum;Thomas S. Uldrick;Adam Bagg;Dale Frank

  • The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity

    Unknown

  • The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies.

    Aziz Bousfiha;Leïla Jeddane;Capucine Picard;Fatima Ailal

  • Infections in 252 patients with common variable immunodeficiency.

    Eric Oksenhendler;Laurence Gérard;Claire Fieschi;Marion Malphettes

  • Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

    Sylvain Choquet;Veronique Leblond;Raoul Herbrecht;Gérard Socié

  • Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.

    Eric Oksenhendler;Monica Duarte;Jean Soulier;Patrice Cacoub

  • High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

    Eric Oksenhendler;Emmanuelle Boulanger;Lionel Galicier;Ming-Qing Du

  • Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

    B. Piqueras;C. Lavenu-Bombled;L. Galicier;F.Bergeron-Van Der Cruyssen

  • Kaposi sarcoma–associated herpesvirus infects monotypic (IgMλ) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders

    Ming-Qing Du;Hongxiang Liu;Tim C. Diss;Hongtao Ye

  • Reduced blood CD123 + (lymphoid) and CD11c + (myeloid) dendritic cell numbers in primary HIV-1 infection

    Jérôme Pacanowski;Sandrine Kahi;Marjorie Baillet;Pierre Lebon

  • International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

    Frits Van Rhee;Peter Voorhees;Angela Dispenzieri;Alexander Fosså

  • Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

    Silvia Ferrari;Friedrich Scheiflinger;Manfred Rieger;Geert Mudde

  • Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

    Emmanuelle Boulanger;Laurence Gérard;Jean Gabarre;Jean-Michel Molina

  • Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey.

    Marie-Olivia Chandesris;Isabelle Melki;Angels Natividad;Anne Puel

  • In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site.

    Stephen J. Hamilton-Dutoit;Martine Raphael;Josée Audouin;Jacques Diebold

Frequent Co-Authors

Lionel Galicier
Lionel Galicier Université Paris Cité
Claire Fieschi
Claire Fieschi Université Paris Cité
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Capucine Picard
Capucine Picard Université Paris Cité
Brigitte Autran
Brigitte Autran Sorbonne University
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Alain Fischer
Alain Fischer Collège de France
Stéphane Blanche
Stéphane Blanche Université Paris Cité
Maxime Seligmann
Maxime Seligmann Grenoble Alpes University
Anne Hosmalin
Anne Hosmalin Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens several pathways, especially when paired with related healthcare fields like nursing. Many students consider advancing their career through specialized programs, such as accelerated RN to NP programs, which fast-track registered nurses to become nurse practitioners, enhancing their clinical expertise and earning potential.

For individuals without a nursing background, pursuing one of the best online BSN programs for non nurses is an excellent entry point. These programs are tailored to help students transition smoothly into nursing, often with flexible online options that accommodate busy schedules.

If you're aiming for quicker entry into the nursing field, looking into the easiest accelerated nursing programs can provide a more accessible path. These programs often have less competitive admission criteria, making them ideal for those eager to start their nursing careers promptly.

Another viable option is exploring LPN programs easy to get into, which provide foundational nursing skills. Licensed Practical Nurse (LPN) programs typically require less time to complete and can be a stepping stone toward more advanced nursing roles or complementary healthcare careers.

Best Scientists Citing Eric Oksenhendler

Trending Scientists